세계의 양자선 치료 시스템 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 유형별, 지역별, 부문별 예측(2024-2030년)

Proton Therapy Systems Market Growth & Trends:

The global proton therapy systems market size is expected to reach USD 1.2 billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030, according to a report by Grand View Research, Inc. The market is primarily driven by increasing number of proton therapy centers, rising number of cancer cases, and growing investments by hospitals to establish these centers.

Growing funds & investments by hospitals, manufacturers, and private investors are also contributing to the growth of this market. For instance, in August 2015, Mevion Medical Systems (U.S.) raised USD 200 million in an equity funding led by HOPU Investments (China) and YuanMing Capital (China). These funds are likely to be used for development of technologically advanced and low-cost products. Furthermore, governments across various geographies are including budgets for establishment of these centers. For instance, in July 2015, the state government of Victoria included nearly AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

In addition, rapid increase in the number of cancer cases globally is anticipated to bolster market growth during the forecast period. According to American Cancer Society, an estimated 1,688,780 new cancer cases are expected to be diagnosed in the U.S. and this disorder is likely to cause nearly 600,920 deaths in 2017. Furthermore, according to The Lancet, the number of women diagnosed with breast tumors is estimated to reach 3.2 million by 2030, which is almost double of 1.7 million in 2015.

Favorable reimbursement policies in the U.S and European countries and rising cancer-related healthcare expenditure in emerging nations is likely to propel the global proton therapy systems market. In addition, decreasing cost of proton therapy, increasing awareness, and rising adoption are expected to boost demand for these systems during the forecast period. However, high costs involved in the establishment of these centers and lack of reimbursement in emerging nations is likely to restrain growth in the coming years.

Proton Therapy Systems Market Report Highlights:

• The equipment segment held majority of the revenue share in 2023 due to rise in the number of contracts for establishment of proton therapy centers
• The multi-room systems accounted for the largest market revenue share of 67.4% in 2030
• North America proton therapy systems market dominated in 2023 and accounted for the market share of 42.7%.
• Asia Pacific proton therapy systems market is estimated to register the fastest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Proton Therapy Systems Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Proton Therapy Systems Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Proton Therapy Systems Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Proton Therapy Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
• 4.3. Equipment
  • 4.3.1. Equipment Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Services
  • 4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Proton Therapy Systems Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Proton Therapy Systems Market: Type Movement Analysis, 2023 & 2030 (USD Million)
• 5.3. Single-Room Systems
  • 5.3.1. Single-Room Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Multi-Room Systems
  • 5.4.1. Multi-Room Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Proton Therapy Systems Market: Regional Estimates & Trend Analysis

• 6.1. Proton Therapy Systems Market Share, By Region, 2023 & 2030 (USD Million)
• 6.2. North America
  • 6.2.1. North America Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Canada Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Mexico Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. UK Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Germany Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. France Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. China
    • 6.4.2.1. China Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Japan
    • 6.4.3.1. Japan Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. India Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. South Korea
    • 6.4.5.1. South Korea Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Australia
    • 6.4.6.1. Australia Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Brazil Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Saudi Arabia
    • 6.6.2.1. Saudi Arabia Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. UAE
    • 6.6.3.1. UAE Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. South Africa
    • 6.6.4.1. South Africa Proton Therapy Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Ion Beam Applications S.A.
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/ Strategic Initiatives
  • 7.4.2. Optivus Proton Therapy, Inc.
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/ Strategic Initiatives
  • 7.4.3. Mevion Medical Systems
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/ Strategic Initiatives
  • 7.4.4. Advanced Oncotherapy plc
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/ Strategic Initiatives
  • 7.4.5. Varian Medical Systems, Inc
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/ Strategic Initiatives
  • 7.4.6. ProTom International, Inc
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/ Strategic Initiatives
  • 7.4.7. Hitachi, Ltd.
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/ Strategic Initiatives
  • 7.4.8. Mitsubishi Corporation
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/ Strategic Initiatives
  • 7.4.9. ProNova Solutions, LLC
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/ Strategic Initiatives
  • 7.4.10. Sumitomo Heavy Industries, Ltd
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Recent Developments/ Strategic Initiatives